Aranesp is used to treat anemia resulting from chronic kidney failure or associated with chemotherapy. It stimulates the bone marrow to increase red blood cell production, thereby raising hemoglobin levels in the blood. This helps reduce fatigue and exhaustion and improve the ability to perform daily activities. It also helps reduce the need for repeated blood transfusions and is an effective treatment for patients suffering from a deficiency in natural red blood cell production.
Aranesp also contributes to improving the quality of life for patients by reducing symptoms of anemia, such as dizziness, shortness of breath, and poor concentration. It also enhances oxygen flow to various tissues, providing greater energy and activity. With regular use under close medical supervision, it can achieve clear positive results and help better control chronic anemia, making it an important part of the integrated treatment plan for patients with kidney failure or those undergoing chemotherapy.